The top 100 Swiss startups of 2014 were announced yesterday evening, and 18 ETH spin-offs were included in the list. What’s more, the startup with the best prospects of success started life at ETH Zurich.
Many young people dream of founding their own company. Despite the associated risks, more and more university graduates are choosing to set up spin-offs and transfer their knowledge and ideas to the market in the form of products and services.
Over 300 spin-offs have been launched at ETH Zurich since 1996, and many have become some of the most successful startups in Switzerland. This is also evident from the fact that several have been earmarked as takeover targets by large-scale enterprises. For example, the ETH spin-off Covagen , which was founded in 2006 by doctoral candidates from ETH Professor Dario Neri’s group, was bought out by a subsidiary of Johnson & Johnson in August this year. The company develops new pharmaceuticals for treating cancer and inflammatory diseases. According to Handelszeitung, the takeover was worth more than CHF 200 million.
ETH spin-offs are regular recipients of awards, and yesterday’s announcement by IFJ (Institut für Jungunternehmen) of the 100 most promising startups of the year was no exception. A total of 18 companies which started out at ETH Zurich made the grade – three were even listed in the top 10.
First place went to InSphero , 2014’s startup with the greatest prospects for success. Founded in 2010, this ETH spin-off produces pinhead-sized tumour and liver tissue which scientists can, for example, use to test whether a particular substance attacks the liver. Up to now, preclinical tests have only been able to detect whether a substance damages the liver in half of the cases. InSphero can increase this rate of detection. This would allow researchers to examine the effects of taking a specific substance multiple times over the course of several days. The startup counts several top international conglomerates from the pharmaceuticals industry among its customer base.
CO2 separation and text recognition
Another ETH spin-off among the top ten is Climeworks in seventh place. The company has developed CO2 collectors enabling pure CO2 to be filtered from the air and used as a raw material for many industrial applications such as automotive fuels (diesel, benzene or methane, for example). This has the potential to reposition CO2, former scourge of the Earth’s climate, as a key component for climate-friendly fuels of the future.
Dacuda rounds out the companies listed in the top ten. Founded in 2008, the ETH spin-off has developed a technology called SLAM Scan, which rapidly scans texts, images and tables, and enables them to be directly edited and shared at the touch of a button with other people and platforms. The LSM 100 Scanner Mouse produced by electronics giant LG Electronics is one of the first products based on this technology and marketed around the world.
Over 300 spin-offs have been launched at ETH Zurich since 1996, and many have become some of the most successful startups in Switzerland. This is also evident from the fact that several have been earmarked as takeover targets by large-scale enterprises. For example, the ETH spin-off Covagen , which was founded in 2006 by doctoral candidates from ETH Professor Dario Neri’s group, was bought out by a subsidiary of Johnson & Johnson in August this year. The company develops new pharmaceuticals for treating cancer and inflammatory diseases. According to Handelszeitung, the takeover was worth more than CHF 200 million.
ETH spin-offs are regular recipients of awards, and yesterday’s announcement by IFJ (Institut für Jungunternehmen) of the 100 most promising startups of the year was no exception. A total of 18 companies which started out at ETH Zurich made the grade – three were even listed in the top 10.
First place went to InSphero , 2014’s startup with the greatest prospects for success. Founded in 2010, this ETH spin-off produces pinhead-sized tumour and liver tissue which scientists can, for example, use to test whether a particular substance attacks the liver. Up to now, preclinical tests have only been able to detect whether a substance damages the liver in half of the cases. InSphero can increase this rate of detection. This would allow researchers to examine the effects of taking a specific substance multiple times over the course of several days. The startup counts several top international conglomerates from the pharmaceuticals industry among its customer base.
CO2 separation and text recognition
Another ETH spin-off among the top ten is Climeworks in seventh place. The company has developed CO2 collectors enabling pure CO2 to be filtered from the air and used as a raw material for many industrial applications such as automotive fuels (diesel, benzene or methane, for example). This has the potential to reposition CO2, former scourge of the Earth’s climate, as a key component for climate-friendly fuels of the future.
Dacuda rounds out the companies listed in the top ten. Founded in 2008, the ETH spin-off has developed a technology called SLAM Scan, which rapidly scans texts, images and tables, and enables them to be directly edited and shared at the touch of a button with other people and platforms. The LSM 100 Scanner Mouse produced by electronics giant LG Electronics is one of the first products based on this technology and marketed around the world.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
